Shopping News / Articles
Google News
pharmaceuticalcommerce. com > shorts > how-will-specialty-launches-change-as-cell-and-gene-therapies-scale-

How Will Specialty Launches Change as Cell and Gene Therapies Scale?

55+ min ago  (26+ words) Pharmaceutical Commerce Trending on Pharmaceutical Commerce How Reusable Plastic Pallets Help Foster Traceability and Security...

Symbols: btc-usd,nasdaq:fblg,nasdaq:fate,nasdaq:meso,nasdaq:lgvn,nasdaq:oncy
Beta Kit
betakit. com > quantum-computing-for-drug-discovery-still-hasnt-had-its-chatgpt-moment-biotech-founder-says

Quantum computing for drug discovery still hasn't had its "Chat GPT moment," biotech founder says

46+ min ago  (180+ words) Quantum chemistry has been touted as having the potential to revolutionize drug discovery. But Mark Fingerhuth, the co-founder and chief research and development officer of Toronto biotech startup Protein Qure, says we're not quite there yet. From the source: Fingerhuth…...

Symbols: nasdaq:qntm
@pharma_indian
indianpharmapost. com > news > quotient-sciences-advances-ai-designed-drug-product-into-phase-i-clinical-study-20380

Quotient Sciences advances AI-designed drug product into Phase I clinical study

3+ hour, 53+ min ago  (218+ words) Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development. Quotient Sciences has announced the successful initiation of a Phase I clinical study evaluating a drug product developed using artificial intelligence…...

Symbols: btc-usd
Spokesman. com
spokesman. com > stories > 05/28/2026 > cvs-returns-zepbound-to-drug-plans-after-lilly-sla

CVS returns Zepbound to drug plans after Lilly slashes price

3+ hour, 52+ min ago  (653+ words) More than 10 million US patients will regain easy access to Eli Lilly & Co. s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans. The reversal comes after Lilly agreed…...

Symbols: nyse:lly
Bio Space
biospace. com > business > kailera-walks-path-paved-by-lilly-in-post-ipo-catalyst-rich-period

Kailera walks path paved by Lilly in post-IPO "catalyst-rich period

1+ hour, 51+ min ago  (356+ words) After a record-breaking $625 million IPO, Kailera Therapeutics will tread a relatively safe road as the biotech's trifecta of obesity drugs follow in the footsteps of one of the industry's leading weight-loss players. "We view Kailera's broad GLP-1-based pipeline as…...

Symbols: nyse:lly
@kalkineuk
kalkinemedia. com > uk > stocks > healthcare > 3-uk-pharma-majors-driving-global-healthcare-innovation

3 UK Pharma Majors Driving Global Healthcare Innovation

2+ hour, 32+ min ago  (42+ words) Kalkine Media Three UK Specialty Engineering Names With Quiet Strength Three UK AI-Enabled Software Names Worth Watching Three UK Energy Majors Worth Watching Through 2026 Three UK Specialty Consumer Names With Distinctive Stories...

Symbols: tsxv:epl,btc-usd,speed-up,level-up,nyse:mrk,nasdaq:tern
Gene Online News
geneonline. com > biopharma-experts-discuss-job-offer-negotiation-strategies-in-employer-favored-market

Biopharma Experts Discuss Job Offer Negotiation Strategies in Employer-Favored Market

11+ hour, 30+ min ago  (110+ words) geneonline. com Biopharma Experts Discuss Job Offer Negotiation Strategies in Employer-Favored Market Biopharma professionals are weighing the benefits of negotiating job offers in the current employer-favored market, according to three industry experts. The discussion centered on common errors made during…...

Symbols: btc-usd
Stevens Point
wsau. com > 05/28/2026 > small-biotech-firms-quicker-to-latch-onto-ai-than-big-ones-says-tencent-healthcare-president

Small biotech firms quicker to "latch onto" AI than big ones, says Tencent Healthcare President

7+ hour, 30+ min ago  (236+ words) HONG KONG, May 28 (Reuters) " Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech giant Tencent's "healthcare division said on Thursday, as more "businesses embrace AI to improve efficiency. Pharmaceutical companies are also increasingly…...

Symbols: nyse:lly
Pulse 2. 0
pulse2. com > cypher-ai-2-million-seed-raised-to-build-ai-native-infrastructure-for-life-science-rd

Cypher AI: $2 Million Seed Raised To Build AI-Native Infrastructure For Life Science R&D

1+ hour, 20+ min ago  (314+ words) Cypher AI, a company building AI-native digital infrastructure for life science research and development, announced it has raised $2 million in seed funding led by Ma C Venture Capital, with participation from Epsilon Ventures, Connecticut Innovations, Sparta Group, and Liquid Metal…...

Symbols: btc-usd,nasdaq:kala
Google News
pennbizreport. com > news > 32723-newtown-based-traws-pharma-advances-experimental-antiviral-therapy

Newtown-based Traws Pharma advances experimental antiviral therapy - Pennsylvania Business Report

7+ hour, 37+ min ago  (407+ words) Home " News " Newtown-based Traws Pharma advances experimental antiviral therapy Traws Pharma Inc. said May 27 that it is advancing development of a proprietary broad-spectrum antiviral combination therapy aimed at combating deadly viruses, including Hantavirus, Ebola, and Lassa fever. The clinical-stage biopharmaceutical…...

Symbols: nasdaq:traw,asx:ila
Shopping

Please enter a search for detailed shopping results.